AGIOS PHARMACEUTICALS INC (AGIO) Stock Balance Sheet
NASDAQ:AGIO - Nasdaq - US00847X1046 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 76.25M | 88.20M | 139.30M | 203.10M | 127.40M | |||
| Marketable Securities | 817.46M | 688.72M | 643.90M | 816.90M | 445.50M | |||
| Receivables | 4.11M | 2.81M | 2.20M | 4.40M | 25.40M | |||
| Inventories | 27.62M | 19.08M | 8.50M | N/A | 14.70M | |||
| Other Current Assets | 40.16M | 35.02M | 39.00M | 39.80M | 23.70M | |||
| Total Current Assets | 965.60M | 833.84M | 832.80M | 1.06B | 636.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 54.55M | 69.79M | 88.10M | 104.20M | 117.50M | |||
| Investments And Advances | 638.32M | 29.43M | 313.90M | 266.40M | 97.60M | |||
| Other Non-Current Assets | 4.72M | 4.06M | 4.00M | 2.90M | 1.10M | |||
| Total Non-Current Assets | 697.60M | 103.28M | 405.90M | 373.50M | 216.30M | |||
| TOTAL ASSETS | 1.66B | 937.12M | 1.24B | 1.44B | 853.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 300.00K | 300.00K | |||
| Accrued Expenses | 63.64M | 58.17M | 44.00M | 42.80M | 67.20M | |||
| Accounts Payable | 16.64M | 9.78M | 18.60M | 16.70M | 26.80M | |||
| Other Current Liabilities | 871.00K | N/A | N/A | 0.00 | 0.00 | |||
| Total Current Liabilities | 81.16M | 67.95M | 62.60M | 59.80M | 94.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 300.00K | 300.00K | |||
| Other Non-Current Liabilities | 41.09M | 58.14M | 75.30M | 85.70M | 358.70M | |||
| Total Non-Current Liabilities | 41.09M | 58.14M | 75.30M | 86.00M | 359.10M | |||
| TOTAL LIABILITIES | 122.24M | 126.10M | 137.90M | 145.80M | 453.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -148.92M | -822.65M | -470.60M | -238.80M | -1.84B | |||
| Additional Paid In Capital | 2.49B | 2.44B | 2.39B | 2.33B | 2.24B | |||
| Common Shares | 73.00K | 72.00K | 100.00K | 100.00K | 100.00K | |||
| Treasury Stock | -802.49M | -802.49M | -802.50M | -802.50M | N/A | |||
| Other Shareholders' Equity | -1.52M | -441.00K | -12.50M | -1.20M | 100.00K | |||
| Shares Outstanding | 57.16M | 55.95M | 55.00M | 54.30M | 69.30M | |||
| Tangible Book Value per Share | 26.96 | 14.50 | 20.01 | 23.79 | 5.76 | |||
| Total Shareholders' Equity | 1.54B | 811.02M | 1.10B | 1.29B | 399.50M | |||
| TOTAL LIABILITIES AND EQUITY | 1.66B | 937.12M | 1.24B | 1.44B | 853.00M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Current Ratio | 11.90 | 12.27 | 13.30 | 17.80 | 6.74 | |||
| Return On Assets (ROA) | 40.51% | -37.57% | -18.71% | 111.62% | -38.38% | |||
| Return On Equity (ROE) | 43.72% | -43.41% | -21.06% | 124.20% | -81.94% | |||
All data in USD , ROIC based on taxRate of 0.21